InsidersTradesSigma
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by 강희철, Chairman & CEO. Insider active across 2 companies, notably 지에프씨생명과학. Aggregated, 38 filings have been published. Activity tracked since 4 March 2026. The latest transaction was filed on 9 April 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations
강희철 is President-CEO of 지에프씨생명과학, listed on XKRX. He has 26 filings in total, and among the recent sampled filings from 2022-12-28 to 2026-07-20, purchases amount to EUR 240799 and sales to EUR 0. The recent filings are purchases, with amounts including EUR 120861.27 on 2026-03-26, EUR 35557.91 on 2026-03-13, EUR 29975.09 and EUR 29071.55907056149 on 2026-04-08, and EUR 12401 and EUR 12388.64150244906 on 2026-04-10.